Intestinal/multivisceral transplantation

Gwenn E McLaughlin, Tomoaki Kato

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Intestinal/multivisceral transplantation has evolved from an experimental procedure to the treatment of choice for patients with irreversible intestinal failure and serious complications related to long-term parenteral nutrition. Children who are likely to suffer permanent intestinal failure and benefit from intestinal transplantation include those with a remaining small bowel length of less than 30-40 cm, absence of the ileocecal valve, colonic resection and malabsorptive syndromes. Indications for transplant include frequent severe bouts of catheter associated sepsis, threatened loss of vascular access and the development of liver cirrhosis from cholestasis. Children who are more likely to experience cholestasis from total parenteral nutrition include those who experience persistent hyperbilirubinemia (greater than 6 mg/dl despite enteral nutrition), those with recurrent sepsis and/or bacterial overgrowth and those with minimal tolerance of any enteral feeds in the first few months post resection. The 1 year survival rate after intestinal transplantation has markedly improved over the last several years but long term survival rates have remained unchanged. The improved short term survival rates have led to an increased prevalence of this patient population in intensive care units. Management of intestinal and multivisceral transplant recipients is uniquely challenging because of complications arising from the high incidence of transplant rejection and its treatment. In the ICU, the complexity of medical care for the transplant recipient requires a multidisciplinary approach with coordination by an intensivist in collaboration with the transplant surgeon, gastroenterologist, and other specialists.

Original languageEnglish (US)
Title of host publicationPediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child
PublisherSpringer-Verlag London Ltd
Pages425-441
Number of pages17
ISBN (Print)9781447163596, 9781447163589
DOIs
StatePublished - Jan 1 2014

Fingerprint

Survival Rate
Transplantation
Cholestasis
Sepsis
Ileocecal Valve
Transplants
Hyperbilirubinemia
Total Parenteral Nutrition
Parenteral Nutrition
Graft Rejection
Enteral Nutrition
Liver Cirrhosis
Small Intestine
Blood Vessels
Intensive Care Units
Catheters
Incidence
Therapeutics
Population
Transplant Recipients

Keywords

  • Acute cellular rejection
  • Antibody mediated rejection
  • Calcineurin inhibitors
  • Chronic rejection
  • Gastroschisis
  • Graft vs. host disease
  • Herpes virus infections
  • Multivisceral transplantation
  • Necrotizing enterocolitis
  • Post-transplant lymphoproliferative disorder
  • Posterior reversible encephalopathy
  • Reactivation
  • Rituximab
  • Tacrolimus
  • Thymoglobulin
  • Viral infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McLaughlin, G. E., & Kato, T. (2014). Intestinal/multivisceral transplantation. In Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child (pp. 425-441). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-6359-6_30

Intestinal/multivisceral transplantation. / McLaughlin, Gwenn E; Kato, Tomoaki.

Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child. Springer-Verlag London Ltd, 2014. p. 425-441.

Research output: Chapter in Book/Report/Conference proceedingChapter

McLaughlin, GE & Kato, T 2014, Intestinal/multivisceral transplantation. in Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child. Springer-Verlag London Ltd, pp. 425-441. https://doi.org/10.1007/978-1-4471-6359-6_30
McLaughlin GE, Kato T. Intestinal/multivisceral transplantation. In Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child. Springer-Verlag London Ltd. 2014. p. 425-441 https://doi.org/10.1007/978-1-4471-6359-6_30
McLaughlin, Gwenn E ; Kato, Tomoaki. / Intestinal/multivisceral transplantation. Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child. Springer-Verlag London Ltd, 2014. pp. 425-441
@inbook{3c4d315a55ec4579b69504e3dcb2af24,
title = "Intestinal/multivisceral transplantation",
abstract = "Intestinal/multivisceral transplantation has evolved from an experimental procedure to the treatment of choice for patients with irreversible intestinal failure and serious complications related to long-term parenteral nutrition. Children who are likely to suffer permanent intestinal failure and benefit from intestinal transplantation include those with a remaining small bowel length of less than 30-40 cm, absence of the ileocecal valve, colonic resection and malabsorptive syndromes. Indications for transplant include frequent severe bouts of catheter associated sepsis, threatened loss of vascular access and the development of liver cirrhosis from cholestasis. Children who are more likely to experience cholestasis from total parenteral nutrition include those who experience persistent hyperbilirubinemia (greater than 6 mg/dl despite enteral nutrition), those with recurrent sepsis and/or bacterial overgrowth and those with minimal tolerance of any enteral feeds in the first few months post resection. The 1 year survival rate after intestinal transplantation has markedly improved over the last several years but long term survival rates have remained unchanged. The improved short term survival rates have led to an increased prevalence of this patient population in intensive care units. Management of intestinal and multivisceral transplant recipients is uniquely challenging because of complications arising from the high incidence of transplant rejection and its treatment. In the ICU, the complexity of medical care for the transplant recipient requires a multidisciplinary approach with coordination by an intensivist in collaboration with the transplant surgeon, gastroenterologist, and other specialists.",
keywords = "Acute cellular rejection, Antibody mediated rejection, Calcineurin inhibitors, Chronic rejection, Gastroschisis, Graft vs. host disease, Herpes virus infections, Multivisceral transplantation, Necrotizing enterocolitis, Post-transplant lymphoproliferative disorder, Posterior reversible encephalopathy, Reactivation, Rituximab, Tacrolimus, Thymoglobulin, Viral infection",
author = "McLaughlin, {Gwenn E} and Tomoaki Kato",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-6359-6_30",
language = "English (US)",
isbn = "9781447163596",
pages = "425--441",
booktitle = "Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Intestinal/multivisceral transplantation

AU - McLaughlin, Gwenn E

AU - Kato, Tomoaki

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Intestinal/multivisceral transplantation has evolved from an experimental procedure to the treatment of choice for patients with irreversible intestinal failure and serious complications related to long-term parenteral nutrition. Children who are likely to suffer permanent intestinal failure and benefit from intestinal transplantation include those with a remaining small bowel length of less than 30-40 cm, absence of the ileocecal valve, colonic resection and malabsorptive syndromes. Indications for transplant include frequent severe bouts of catheter associated sepsis, threatened loss of vascular access and the development of liver cirrhosis from cholestasis. Children who are more likely to experience cholestasis from total parenteral nutrition include those who experience persistent hyperbilirubinemia (greater than 6 mg/dl despite enteral nutrition), those with recurrent sepsis and/or bacterial overgrowth and those with minimal tolerance of any enteral feeds in the first few months post resection. The 1 year survival rate after intestinal transplantation has markedly improved over the last several years but long term survival rates have remained unchanged. The improved short term survival rates have led to an increased prevalence of this patient population in intensive care units. Management of intestinal and multivisceral transplant recipients is uniquely challenging because of complications arising from the high incidence of transplant rejection and its treatment. In the ICU, the complexity of medical care for the transplant recipient requires a multidisciplinary approach with coordination by an intensivist in collaboration with the transplant surgeon, gastroenterologist, and other specialists.

AB - Intestinal/multivisceral transplantation has evolved from an experimental procedure to the treatment of choice for patients with irreversible intestinal failure and serious complications related to long-term parenteral nutrition. Children who are likely to suffer permanent intestinal failure and benefit from intestinal transplantation include those with a remaining small bowel length of less than 30-40 cm, absence of the ileocecal valve, colonic resection and malabsorptive syndromes. Indications for transplant include frequent severe bouts of catheter associated sepsis, threatened loss of vascular access and the development of liver cirrhosis from cholestasis. Children who are more likely to experience cholestasis from total parenteral nutrition include those who experience persistent hyperbilirubinemia (greater than 6 mg/dl despite enteral nutrition), those with recurrent sepsis and/or bacterial overgrowth and those with minimal tolerance of any enteral feeds in the first few months post resection. The 1 year survival rate after intestinal transplantation has markedly improved over the last several years but long term survival rates have remained unchanged. The improved short term survival rates have led to an increased prevalence of this patient population in intensive care units. Management of intestinal and multivisceral transplant recipients is uniquely challenging because of complications arising from the high incidence of transplant rejection and its treatment. In the ICU, the complexity of medical care for the transplant recipient requires a multidisciplinary approach with coordination by an intensivist in collaboration with the transplant surgeon, gastroenterologist, and other specialists.

KW - Acute cellular rejection

KW - Antibody mediated rejection

KW - Calcineurin inhibitors

KW - Chronic rejection

KW - Gastroschisis

KW - Graft vs. host disease

KW - Herpes virus infections

KW - Multivisceral transplantation

KW - Necrotizing enterocolitis

KW - Post-transplant lymphoproliferative disorder

KW - Posterior reversible encephalopathy

KW - Reactivation

KW - Rituximab

KW - Tacrolimus

KW - Thymoglobulin

KW - Viral infection

UR - http://www.scopus.com/inward/record.url?scp=84948983098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948983098&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-6359-6_30

DO - 10.1007/978-1-4471-6359-6_30

M3 - Chapter

SN - 9781447163596

SN - 9781447163589

SP - 425

EP - 441

BT - Pediatric Critical Care Medicine: Volume 4: Peri-Operative Care of the Critically Ill or Injured Child

PB - Springer-Verlag London Ltd

ER -